BTMD - Company ID 0001819253
The table below shows biote Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $44.23M | $44.94M | $47.96M | $48.86M | $48.99M | $51.38M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
biote Corp. reported annual revenue of $192.22M for fiscal year 2025. That is down 2.5% from $197.19M in fiscal 2024. Over the 5 fiscal years shown, annual revenue grew from $139.40M (FY 2021) to $192.22M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $32.43M |
| $27.79M |
| $26.15M |
| $24.22M |
| $26.69M |
| $23.92M |
| Operating income | -$3.51M | $3.17M | $8.27M | $10.77M | $9.69M | $12.18M |
| Income tax | $296.00K | $662.00K | -$765.00K | $2.15M | $1.62M | $3.20M |
| Net income | -$6.56M | $2.28M | $8.19M | $3.19M | $13.72M | $10.70M |
| EPS (diluted) | -$0.23 | $0.06 | $0.22 | $0.10 | $0.37 | $0.33 |